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Newcastle disease virus assembles in plasma membrane domains with properties of membrane lipid rafts,
and disruption of these domains by cholesterol extraction with methyl--cyclodextrin resulted in the release of
virions with irregular protein composition, abnormal particle density, and reduced infectivity (J. P. Laliberte,
L. W. McGinnes, M. E. Peeples, and T. G. Morrison, J. Virol. 80:10652–10662, 2006). In the present study, these
results were confirmed using Niemann-Pick syndrome type C cells, which are deficient in normal membrane
rafts due to mutations affecting cholesterol transport. Furthermore, cholesterol extraction of infected cells
resulted in the release of virions that attached to target cells at normal levels but were defective in virus-cell
membrane fusion. The reduced fusion capacity of particles released from cholesterol-extracted cells correlated
with significant loss of HN-F glycoprotein-containing complexes detected in the virion envelopes of these
particles and with detection of cell-associated HN-F protein-containing complexes in extracts of cholesterol-
extracted cells. Extraction of cholesterol from purified virions had no effect on virus-cell attachment, virus-cell
fusion, particle infectivity, or the levels of glycoprotein-containing complexes. Taken together, these results
suggest that cholesterol and membrane rafts are required for the formation or maintenance of HN-F glyco-
protein-containing complexes in cells but not the stability of preformed glycoprotein complexes once assembled
into virions.
Membrane architecture and lipid organization are important
for many cellular and molecular processes, including protein
trafficking, signal transduction, and immunological synapse
formation (41). In recent years, the roles of cholesterol and
sphingolipids in forming distinct membrane microdomains,
termed membrane lipid rafts, have become recognized as im-
portant in these processes. The inclusion or concentration of
specific molecules in these domains and the exclusion of others
likely increases the specificity and efficiency of molecular
events occurring at membrane surfaces (40).
The participation of membrane lipid raft domains in the
assembly and release of many different enveloped RNA vi-
ruses, including retroviruses, filoviruses, orthomyxoviruses, and
paramyxoviruses, is well-documented (30). Evidence for lipid
raft involvement in virus assembly includes the presence of
lipid raft-associated molecules in purified virions, colocaliza-
tion of viral structural proteins with lipid raft markers, and the
biochemical association of viral proteins with lipid raft mem-
branes as defined by detergent-resistant membranes (DRMs)
(30, 43). Furthermore, extraction of cholesterol from cellular
plasma membranes using methyl--cyclodextrin (mCD) re-
sulted in altered release of several different viruses (33), in-
cluding human immunodeficiency virus. However, the biolog-
ical significance of these observations has not been resolved.
Newcastle disease virus (NDV), an avian paramyxovirus (19,
45), also assembles in membrane lipid raft domains (18). Ev-
idence for this conclusion was, first, that lipid raft protein
markers caveolin-1 and flotillin-2 were found in purified NDV
virions, while a non-lipid raft marker, transferrin receptor, was
absent. Second, three of the four main structural components
of NDV, the nucleocapsid (NP), hemagglutinin-neuraminidase
(HN), and fusion (F) proteins, fractionated with detergent-
resistant membranes. Third, a kinetic analysis of DRM asso-
ciation and virion incorporation of each of the viral proteins
strongly suggested that assembly occurred in lipid raft do-
mains. The importance of these domains in NDV assembly was
suggested by the observation that extraction of plasma mem-
brane cholesterol with mCD (15, 37, 40) stimulated the re-
lease of structurally abnormal particles with reduced infectivity
(18). Reduced particle infectivity could not be attributed to the
lower levels of cholesterol in virus envelopes, since direct cho-
lesterol depletion of purified virion membranes had no signif-
icant effect on infectivity (18). Together with previous results in
other virus systems, these results implied that proper assembly
was dependent on cholesterol in the assembly membrane.
However, the known side effects of mCD, most notably the
rearrangement of the cortical membrane cytoskeleton (17),
could not be excluded as the primary cause of the effects of
mCD on the assembly and release of infectious virus.
These studies were extended in order to clarify the func-
tional role of cholesterol in NDV assembly. First, character-
ization of virus released from Niemann-Pick syndrome type C
(NPC) fibroblasts, which are deficient in functional membrane
lipid rafts, showed that cholesterol depletion without affecting
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the cytoskeleton resulted in abnormal NDV release. Choles-
terol depletion of infected-cell membranes resulted in the re-
lease of virions with normal virus-cell attachment activity but
significantly reduced virus-cell fusion activity. These results
correlated with loss of detection of HN-F glycoprotein com-
plexes in infected cells and with reduced detection of glyco-
protein-containing complexes in virions released from choles-
terol-depleted cells. However, direct extraction of cholesterol
from the virion envelope had no effect on the detection of
HN-F protein-containing complexes or virion attachment and
fusion activities. Taken together, the results show that intact
lipid raft domains in assembly membranes of infected cells
facilitate the proper viral glycoprotein interactions necessary
for the generation of a functional and infectious virus particle.
MATERIALS AND METHODS
Cells, virus, and reagents. Normal human embryonic lung (HEL) fibroblasts
(a kind gift from Timothy Kowalik, University of Massachusetts Medical School)
and Niemann-Pick syndrome type C human fibroblasts (NIH Coriell Cell Re-
pository GM03123) were maintained in Dulbecco’s modified Eagle medium
(DMEM) supplemented with penicillin-streptomycin, L-glutamine, vitamins,
nonessential amino acids, and 10% fetal calf serum (FCS). East Lansing Line
(ELL-0) avian fibroblasts from American Type Culture Collection were main-
tained in DMEM supplemented with penicillin-streptomycin and 10% FCS.
NDV strain AV (under biosafety level 3 conditions) and NDV strain B1 stocks
were prepared by growth in eggs by standard protocols (26). Methyl--cyclodex-
trin (Sigma-Aldrich) was resuspended in DMEM. Lovastatin (Sigma-Aldrich)
was prepared in H2O and activated as described previously (8). Triton X-100 was
purchased from Pierce Biotechnology.
Antibodies. Anti-NDV antibody was raised against UV-inactivated NDV viri-
ons (27). Anti-M protein antibody was a monoclonal antibody obtained from
Mark Peeples (Ohio State University) (7). HN protein-specific antibodies were
anti-A (24), anti-AS (25), and anti-H (38). F protein-specific antibodies were
anti-HR1 (23), anti-HR2 (6), anti-Ftail (45), anti-F2-96 (an antipeptide antibody
raised against amino acids 76 to 96) (24) and anti-Fu1a (29).
Infections and radioactive labeling. HEL and NPC cells seeded at approxi-
mately 3.0  104 cells per 35-mm plate and ELL-0 cells seeded at approximately
6.0  105 cells per 35-mm plate were grown overnight and then infected with
NDV at a multiplicity of infection of 10 in 0.25 ml of medium (under biosafety
level 3 conditions for strain AV). After 45 min, 1 ml of medium was added, and
monolayers were incubated for 5 to 8 h. For radioactive labeling, cells were
radiolabeled at 6 h postinfection for 1 h at 37°C in DMEM supplemented with
50 Ci of [35S]methionine and cysteine per ml (New England Nuclear). At the
end of the labeling period, cells were incubated with chase medium (DMEM
supplemented with 0.1 mM cold methionine without FCS) for the indicated
lengths of time.
Virus purification. Culture supernatants were clarified by centrifugation at
5,000 rpm for 5 min, and then particles in the supernatant were sedimented
through 20% sucrose (wt/vol) to a 20 to 65% sucrose interface (24,000 rpm for
10 to 12 h at 4°C using a Beckman SW50.1 rotor). For virion flotation, purified
virus taken from 20 to 65% sucrose interface fractions was adjusted to 60%
sucrose (wt/vol) and overlaid on top of 80% (1.24-g/cm3) sucrose. The sucrose
layer-containing virus was then overlaid with 1 ml of 50% sucrose, 1 ml of 38%
sucrose, and 0.5 ml of 10% sucrose in a SW50.1 tube. Samples were subjected to
centrifugation at 100,000  g for 18 h at 4°C.
Polyacrylamide gel electrophoresis and Western analysis. To prepare cell
extracts, cell monolayers were washed in cold phosphate-buffered saline (PBS)
and lysed in TNE buffer (25 mM Tris-HCl, pH 7.4, 150 mM NaCl2, and 5 mM
EDTA) containing 1% Triton X-100 and 2.5 mg/ml of N-ethylmaleimide. Pro-
teins were resolved on 8% polyacrylamide gels by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) as previously described (18). Pro-
teins were detected by Western analysis as previously described (18).
Radioactively labeled proteins were detected by autoradiography as previously
described (18). Signals in autoradiographs were quantified using a Fluor-S phos-
phorimager (Bio-Rad).
Isolation of DRMs. Cell monolayers were washed once in ice-cold PBS, and
cells were lysed in ice-cold TNE buffer containing 1% Triton X-100 and 2.5
mg/ml N-ethylmaleimide. Lysates were incubated on ice at 4°C for 30 min, and
DRMs in extracts were isolated by flotation in sucrose gradients as previously
described (18). Gradient fractions were collected from the bottom of the gradi-
ent (each fraction was 0.25 ml except for the second fraction, which had a volume
of 1 ml). Proteins in each fraction were resolved by 8% SDS-PAGE and detected
by Western analysis with the appropriate primary and secondary antibodies.
After centrifugation, the densities of all sucrose fractions were measured using a
refractometer.
Extraction of cholesterol. ELL-0 cells seeded on 35-mm plates were infected
and radiolabeled for 1 h as described above. At the end of the labeling period,
monolayers were incubated with chase medium (DMEM supplemented with 0.1
mM cold methionine only) for 1 h. Cells were then either left untreated or
treated with 10 mM mCD and 4 g/ml lovastatin for 1 h in DMEM supple-
mented with 0.1 mM cold methionine at 37°C. The medium was then removed
and replaced with complete DMEM containing lovastatin, and cells were further
incubated for 1 h (immunoprecipitation experiments) or 4 h (virion experi-
ments). Excluding the experiments depicted in Fig. 8, at no time were virus
particles incubated in the presence of mCD.
For the experiments shown in Fig. 8, extraction of cholesterol from NDV
particles was performed as described previously (18). Briefly, nonradiolabeled or
35S-radiolabeled, gradient-purified NDV (strain AV) virions from untreated
ELL-0 cells were mixed with DMEM or with increasing concentrations of mCD
in DMEM and incubated for 1 h at 37°C. The virus was purified away from
mCD-cholesterol complexes by sedimentation through 20% sucrose as de-
scribed above.
Immunofluorescence of surface HN and F glycoproteins. HEL, NPC, and
ELL-0 cells were grown to confluence on glass coverslips in 35-mm plates and
infected with NDV (strain AV) for 7 h. Cells were then left untreated or treated
with 10 mM mCD and 4 g/ml lovastatin for 1 h, followed by a 1-h recovery in
DMEM in the presence of lovastatin. Cells were then washed twice with ice-cold
immunofluorescence buffer (IF buffer) (PBS containing 1% bovine serum albu-
min, 0.02% sodium azide, and 5 mM CaCl2), fixed with 2% paraformaldehyde for
10 min on ice, and blocked with IF buffer overnight at 4°C. Cells were then
incubated for 1 h at 4°C in IF buffer containing HN protein-specific rabbit anti-H
antibody or F protein-specific mouse anti-Fu1a antibody. Following three washes
with ice-cold IF buffer, cells were incubated for 1 h at 4°C in IF buffer containing
Alexa Fluor 488-conjugated goat anti-rabbit antibody (Molecular Probes) or
Alexa Fluor 568-conjugated goat anti-mouse antibody (Molecular Probes).
Monolayers were then washed three times with ice-cold IF buffer and incubated
for 20 min on ice with IF buffer containing Hoechst nucleus stain (Molecular
Probes). Cells were washed twice with ice-cold IF buffer and mounted on slides
using Vectashield mounting medium (Vector Laboratories) for fluorescence
microscopy. Fluorescence images were acquired using a Nikon fluorescence
microscope and Openlab software.
Coimmunoprecipitation of viral proteins. Coimmunoprecipitation was done
by the method of McGinnes and Morrison (24). Briefly, equivalent volumes of
cellular extracts were incubated overnight at 4°C with a cocktail of HN protein-
specific antibodies (anti-A, anti-AS, and anti-H) or a cocktail or F protein-
specific antibodies (anti-HR1, anti-HR2, anti-Fu1a, anti-Ftail, and anti-F2-96) or
in the absence of antibody. Antibody complexes were precipitated with Pan-
sorbin cells, washed three times in TNE buffer containing 0.5% Triton X-100,
and prepared for SDS-PAGE as described above. For DRM gradient fractions,
equivalent volumes of sucrose fractions were adjusted to 1% Triton X-100 and
incubated overnight at 4°C with the cocktail of HN protein-specific antibodies or
F protein-specific antibodies or in the absence of antibody. Antibody complexes
were precipitated with Pansorbin cells, washed three times in TNE buffer con-
taining 0.5% Triton X-100, and prepared for SDS-PAGE. The amount of each
protein precipitated in the no-antibody sample, due to protein aggregation or
nonspecific association of the proteins with Pansorbin cells, was subtracted from
the amount of glycoprotein specifically precipitated when NDV-specific antibody
was present.
Sorting of virions. 35S-radiolabeled virus (strain AV) was purified by sedimen-
tation through 20% sucrose and subsequently floated as described above. Equiv-
alent amounts of intact virions with normal particle density (1.18 to 1.20 g/cm3)
(18) were incubated overnight at 4°C with either polyclonal anti-NDV antibody,
HN protein-specific anti-H antibody, or a cocktail of F protein-specific antibod-
ies (anti-HR1, anti-HR2, anti-F2-96, and anti-Fu1a) or in the absence of anti-
body. Antibody-virus complexes were precipitated with Pansorbin cells and
washed with cold TNE buffer. The precipitated virions were then adjusted to 1%
Triton X-100 to lyse virions. All viral proteins were then immunoprecipitated
with a cocktail of NDV-specific antibodies and Pansorbin cells. Precipitates were
washed three times in PBS containing 0.4% SDS, and proteins were prepared for
SDS-PAGE as described above. To calculate sorting efficiency, background (no-
antibody controls) values were subtracted, and then background-adjusted values
were divided by the total amount precipitated with anti-NDV antibody.
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Virus-cell binding. 35S-radiolabeled, gradient-purified NDV (strain AV) virus
from untreated or mCD-treated ELL-0 cells was incubated with chilled, con-
fluent ELL-0 cell monolayers for 1 h on ice at 4°C in cold Ca2-rich DMEM.
Monolayers were then washed gently three times with cold PBS, and cell extracts
were prepared as outlined above. All viral proteins were immunoprecipitated
and prepared for SDS-PAGE as described above. The specificity control con-
sisted of preincubation of an equivalent amount of virions with neutralizing
anti-NDV antibody for 30 min at room temperature prior to binding with cell
monolayers. To calculate binding efficiency, an equivalent amount of virions was
immediately lysed, and all viral proteins were immunoprecipitated for the assay
input.
Virus-cell fusion. For visualization of R18 virus-cell fusion by fluorescence
microscopy, gradient-purified NDV (strain AV) from untreated ELL-0 cells was
incubated with R18 (octadecyl rhodamine B; Molecular Probes) for 1 h at room
temperature in the dark. R18-loaded particles were purified away from excess
R18 by sedimentation through 20% sucrose as described above. ELL-0 cells,
grown to confluence on glass coverslips in 35-mm plates, were incubated with
R18-loaded virus for 60 min at 4°C on ice. Unbound virions were removed, and
cell monolayers were washed three times with cold PBS. Cells were either
immediately fixed with 2% paraformaldehyde after virus binding or shifted to
37°C for further incubation prior to fixation. Nuclei were stained, and fluores-
cence images were acquired as outlined above. The specificity control consisted
of preincubation of an equivalent amount of virions with neutralizing anti-NDV
antibody for 30 min at room temperature prior to binding with cell monolayers.
For quantitative R18 virus-cell fusion, gradient-purified NDV (strain B1) from
untreated or mCD-treated avian ELL-0 cells was incubated with acetylated
trypsin (Sigma-Aldrich) to cleave virion F proteins for 15 min at 37°C as de-
scribed by Connolly and Lamb (3). Particles were then incubated with soybean
trypsin inhibitor (Sigma-Aldrich) for 15 min at room temperature. Virions were
then incubated with R18 for 1 h at room temperature in the dark and repurified
as described above. Virions were then incubated with chilled guinea pig eryth-
rocytes (Bio-Link, Inc.) in 24-well plates for 1 h on ice at 4°C in the dark. Upon
incubation of plates at 37°C, R18 fluorescence (excitation, 560 nm; emission, 590
nm) from wells containing virus and erythrocytes was read at 10-min intervals
with a SpectraMax Gemini XS (Molecular Devices) and SoftMax Pro software
(Molecular Devices). At the end of 60 min at 37°C, wells were adjusted to 1%
Triton X-100 to obtain maximum R18 fluorescence, and experimental values
were normalized as described previously (3, 12, 36).
RESULTS
Assembly of NDV in Niemann-Pick syndrome type C human
fibroblasts. We have previously reported that extraction of
cholesterol from NDV-infected cell membranes with methyl-
-cyclodextrin resulted in the release of structurally abnormal
virus particles with reduced infectivity (18). However, incuba-
tion of cells with mCD also results in alterations of the actin
cytoskeleton (17). To determine the importance of plasma
membrane cholesterol in assembly of NDV in the absence of
mCD effects on the cytoskeleton, assembly of NDV in NPC
cells was characterized. NPC cells are human fibroblasts with
mutations in one or two genes, NPC1 and NPC2, which result
in defective transport of cholesterol to cell plasma membranes
and aberrant membrane lipid raft domains (14). Normal hu-
man embryonic lung fibroblasts were used as wild-type coun-
terparts for comparison. In contrast to comparisons of un-
treated and mCD-treated avian cells (18), the actin
cytoskeleton of NPC cells was similar to that of HEL cells (Fig.
1A). HEL and NPC cells were equally permissive to NDV
infection. As shown in Fig. 1B, when comparable numbers of
HEL and NPC cells were infected with NDV, similar levels of
viral protein expression were observed in cellular extracts at
8 h postinfection.
Plasma membrane cholesterol is primarily associated with
liquid-ordered domains or membrane lipid rafts (40). These
specialized cell surface domains are thought to be experimen-
tally reflected in detergent-resistant membranes, which may be
isolated by flotation into sucrose gradients after lysis of cells
with nonionic detergents, usually Triton X-100, at 4°C (40). It
has been recently recognized that there are two density classes
of DRMs, classical DRMs (termed DRM-L with densities of
1.09 to 1.13 g/cm3) and heavier (higher-density) DRMs (DRM-
H), which associate with cytoskeletal components and display
buoyant densities of 1.14 to 1.18 g/cm3 (30). The partitioning of
the viral proteins with these DRMs from HEL and NPC cells
is shown in Fig. 1C. In results very similar to those observed
using infected avian cells, both classes of DRMs from HEL
cells contained the hemagglutinin-neuraminidase glycoprotein
and the nucleocapsid protein, while the fusion glycoprotein
primarily fractionated with DRM-L domains (Fig. 1C). In con-
trast, significantly reduced amounts of HN and F proteins as
well as NP in infected NPC cell extracts fractionated with
DRMs (Fig. 1C). These results are consistent with the abnor-
mal lipid raft domains in NPC cells (22).
The release of virus particles from equivalent numbers of
infected HEL and NPC cells is shown in Fig. 1D to F. Based
upon amounts of NP in purified virions, particle release from
NPC cells was enhanced approximately threefold over particle
release from HEL cells (Fig. 1D). However, particles released
from NPC cells possessed comparable levels of HN protein and
slightly reduced amounts of F protein compared to particles re-
leased from HEL cells, suggesting there was less glycoprotein per
virion in particles released from NPC cells (Fig. 1D).
A comparison of the infectivity of particles released from
equivalent numbers of infected HEL and NPC cells showed
that infectivity of NPC cell-derived particles was reduced ap-
proximately one log unit (PFU/ml) compared to that of HEL
cell-derived particles (Fig. 1E). Upon normalization of the
infectivity of particles for their NP content, the infectivity of
NPC cell-derived particles was approximately 1.5 log unit
(PFU/ml) lower than that of particles generated from HEL
cells (Fig. 1F). These results, which are very similar to those
obtained with untreated and mCD-treated avian cells (18),
support the conclusion that plasma membrane cholesterol and
lipid raft domains have a role in the ordered assembly of
infectious NDV particles. The results also suggest that the
mCD-induced actin rearrangement is not likely the primary
cause of the abnormal virus release from infected cells treated
with mCD (18).
Functional properties of particles released from mCD-
treated cells. To determine the reasons for the decreased in-
fectivity of particles released from mCD-treated cells (18),
attachment of these particles to cells and the fusion of these
particles to cell membranes were quantified. The binding ac-
tivities of 35S-radiolabeled virions, released from untreated or
mCD-treated avian cells, are shown in Fig. 2A and B. Ap-
proximately 21% of input particles released from untreated
cells bound to target cells, while prior incubation with neutral-
izing antibody (32) reduced binding to 1% (Fig. 2B). Simi-
larly, 28% of input particles released from mCD-treated cells
bound to target monolayers, and prior incubation with neu-
tralizing antibody also blocked this binding (Fig. 2B). Thus, cell
binding efficiency of particles released from cholesterol-de-
pleted cells was similar to that of normal virions.
The virus-cell membrane fusion activity of these particles
was monitored with a R18 fluorescence-based assay, similar to
ones described previously (3, 12, 36). The transfer of self-
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quenched R18 dimers from viral membranes to that of target
erythrocyte membranes involves a hemifusion event, which is
mediated by an activated, functional F protein on the viral
membrane (28). Fusion is measured by the dequenching of
R18 as it spreads into the larger erythrocyte membrane, re-
sulting in increased R18 fluorescence.
The demonstration that this assay can be used to monitor
NDV particle fusion with avian cells is shown in Fig. 2C. When
virus was bound to cells at 4°C only, no transfer or dequench-
ing of R18 into cell monolayers was observed (Fig. 2C, panel
ii). However, incubation of virus-bound cells at 37°C for 30 min
or 60 min (Fig. 2C, panel iii or iv, respectively) resulted in
transfer and dequenching of R18 into cell monolayers. The
transfer of R18 from virions to cells was specific, as preincubation
of virus with neutralizing anti-NDV antibody significantly re-
duced the number of R18-positive cells (Fig. 2C, panel v).
These results were quantified, and the kinetics of virus-cell
fusion was determined using a fluorescence plate reader. The
hemifusion kinetics of virions released from untreated cells
with target cells commenced approximately 10 min following
FIG. 1. Abnormal assembly and release of NDV from Niemann-Pick syndrome type C human fibroblasts. (A) Actin distribution of normal
human fibroblasts (HEL) and NPC fibroblasts. Uninfected HEL and NPC cells, treated with 0.05% Triton X-100, were incubated with phalloidin
(actin panels) for 1 h at 4°C prior to Hoechst staining (panels labeled nuclei). (B) Proteins in uninfected () and NDV (B1)-infected () HEL
and uninfected and NDV (B1)-infected NPC fibroblasts were resolved by SDS-PAGE under nonreducing conditions, and viral proteins were
detected by Western analysis with anti-NDV specific antibodies. M, matrix protein; NP, nucleocapsid protein; F0, uncleaved fusion protein; HN,
hemagglutinin-neuraminidase protein. (C) DRMs in extracts of NDV (AV)-infected HEL and NPC cells were isolated by flotation in sucrose
gradients as described in Materials and Methods. Proteins present in DRM gradient fractions were detected by Western analysis using anti-NDV
(NP), anti-AS (HN protein), or anti-HR2 (F protein). Each lane contains 12% of the corresponding gradient fraction, except for fraction 2, which
contains 3% of the total. Densities of each gradient fraction are indicated as g/cm3. Sol, detergent-soluble gradient fractions; DRM-H, heavy
(high-density) DRM gradient fractions; DRM-L, light (low-density) DRM gradient fractions; F1, cleaved fusion protein. (D) The amounts of NP,
HN, and F1 protein present in purified virions released from equivalent numbers of NDV (AV)-infected HEL and NPC cells detected by Western
analysis as described above for panel C. Replicate experiments were quantified by densitometry, and the amount of each protein is represented
relative to the amounts detected in virions from HEL cells. (E) Infectivity (PFU/ml), determined by plaque assay as described previously (18, 26),
of purified virions released from comparable numbers of NDV (AV)-infected HEL and NPC cells. (F) Infectivity (PFU/ml) normalized for NP
protein levels quantified in virions released from comparable numbers of NDV (AV)-infected HEL and NPC cells. Error bars indicate standard
deviations.
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FIG. 2. Attachment and fusion activities of virions released from untreated and mCD-treated cells. 35S-radiolabeled virions released
from untreated or mCD-treated NDV (AV)-infected ELL-0 cells were purified, and their virus-cell attachment and virus-cell hemifusion
activities were characterized as described in Materials and Methods. (A) A representative autoradiograph of cell binding of virions released
from untreated and mCD-treated cells. Virus was bound to avian ELL-0 cells on ice at 4°C for 1 h. Monolayers were washed and lysed,
and viral proteins, immunoprecipitated with a cocktail of anti-NDV specific-antibodies, were resolved by SDS-PAGE under reducing
conditions. Radiolabeled viral proteins are indicated on the right. Lanes: input, virions immediately lysed without cell binding and viral
proteins immunoprecipitated with a cocktail of anti-NDV-specific antibodies;  -NDV, equivalent amount of virions preincubated with
neutralizing anti-NDV-specific antibody prior to incubation with cell monolayers; bound, virus bound to cell monolayers. (B) Binding
efficiency of particles represented as a percentage of total input radiolabeled HN protein among particles released from untreated cells
(black bar) and mCD-treated cells (gray bar) bound to cell monolayers. Cells were treated with () or without () mCD and anti-NDV
antibodies (-NDV). Results are averages of three experiments, and error bars indicate standard deviations. (C) NDV-cell fusion visualized
by dequenching of R18 upon fusion of R18-loaded virions with ELL-0 cells. Virus (strain AV [generated from untreated ELL-0 cells]) was
incubated with cells at 4°C for 60 min only (panel ii), virus was bound at 4°C for 60 min and then incubated at 37°C for 30 min or 60 min
(panels iii and iv, respectively), or virus that had been preincubated with neutralizing anti-NDV antibody was incubated at 4°C for 60 min
and then at 37°C for 30 min (panel v). (D) Kinetics of R18 dequenching and fluorescence upon incubation of R18-loaded NDV (strain B1),
released from untreated or mCD-treated cells, with untreated and neuraminidase (NA)-treated target erythrocytes at 37°C. Results are
averages of three experiments, and error bars indicate standard deviations. Results with open symbols were identical and overlap. R18
fluorescence is shown in arbitrary (arb.) units.
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incubation at 37°C and peaked at 40 to 60 min (Fig. 2D). At 60
min at 37°C, the extent of hemifusion of particles released
from untreated cells was approximately threefold higher than
that of particles released from mCD-treated cells (Fig. 2D).
Both hemifusion events were specific, as incubation of particles
with neuraminidase-treated cells did not result in transfer or
dequenching of R18 (Fig. 2D). Thus, particles released from
mCD-treated cells are deficient in virus-cell hemifusion.
Incorporation of HN-F glycoprotein-containing complexes
into virions. Reduced virus-cell hemifusion could be due to
reduced virion incorporation of F protein or the packaging of
nonfunctional F protein into particles. To address the former
possibility, virions were “sorted” with mono-specific antibody,
and levels of one glycoprotein were quantified following pre-
cipitation of intact particles with antibody specific for the other
glycoprotein. 35S-radiolabeled virions, released from untreated
and mCD-treated avian cells, were incubated with antibody
specific for the HN protein or a cocktail of antibodies specific
for the F protein. Total particles were precipitated with anti-
NDV antibody, and nonspecific precipitation was monitored
by omission of antibody. Representative autoradiographs of
proteins in precipitated particles are shown in Fig. 3A along
with quantification of HN and F protein levels (Fig. 3B and C,
respectively) within antibody-sorted particles.
Specific precipitation of virion HN protein with HN protein-
specific antibody resulted in recovery of approximately 100%
of HN protein-containing particles released from untreated
cells (Fig. 3B), and the majority of HN protein-containing
particles released from untreated cells were precipitated with F
protein-specific antibodies (Fig. 3B). Very similar results were
obtained with virions released from mCD-treated cells (Fig.
3B), indicating that all particles contained some level of HN
protein. Precipitation of particles with anti-HN protein anti-
body resulted in recovery of virion-associated F protein similar
to that recovered after precipitation with anti-F protein anti-
bodies among virions released from either untreated or
mCD-treated cells (Fig. 3C). Taken together, these results
suggested that the majority of particles released from mCD-
treated cells possessed both HN and F glycoproteins within the
same virus particle.
HN-F protein-containing complexes in virion envelopes.
Given that most particles contain at least some of both the HN
proteins and F proteins, we next addressed the effects of cel-
lular cholesterol depletion on packaging of HN-F glycopro-
tein-containing complexes into virions (Fig. 4). Virions re-
leased from untreated or mCD-treated cells were lysed, and
the extent of coimmunoprecipitation of the HN and F proteins
was quantified. A representative result of HN and F protein
coimmunoprecipitation is depicted in Fig. 4A with quantified
results shown in Fig. 4B and C. Approximately 40% of the total
virion HN protein in particles released from untreated cells
was precipitated with F protein-specific antibodies (Fig. 4B),
while in the reciprocal immunoprecipitation, 35% of the total
F protein was precipitated with HN protein-specific antibodies
(Fig. 4C). In contrast, only 20% of the total HN protein in
particles released from mCD-treated cells was precipitated
with F protein-specific antibodies (Fig. 4B). In the reciprocal
immunoprecipitation, the amount of total F protein precipi-
tated with HN protein-specific antibodies was reduced three-
fold (Fig. 4C). The significant reduction in virion-associated
FIG. 3. Precipitation of intact particles with glycoprotein-specific antibodies. Intact 35S-radiolabeled virions released from untreated or
mCD-treated NDV (AV)-infected ELL-0 cells were purified and immunoprecipitated by either polyclonal anti-NDV antibody, HN protein-
specific antibody, a mix of F protein-specific antibodies, or no antibody () as described in Materials and Methods. Ab, antibody; -NDV,
anti-NDV antibody. (A) A representative autoradiograph of the HN and F protein content of particles released from untreated and mCD-treated
cells precipitated with anti-NDV antibody, no antibody (), anti-HN protein antibody, or anti-F protein antibodies. The virus particle origin is
indicated above the gels, and radiolabeled viral proteins are indicated to the right of the gels. HN protein lanes were from polyacrylamide gels
electrophoresed under reducing conditions, while F protein lanes were from polyacrylamide gels electrophoresed under nonreducing conditions.
(B) Amounts of radiolabeled HN protein in particles released from untreated cells (black bars) and mCD-treated cells (gray bars). Particles were
precipitated or “sorted” with antibodies as indicated at the bottom of panel and as described in Materials and Methods. Data are represented as
percentages of total HN protein precipitated with anti-NDV. The no-antibody () values were subtracted from each precipitation. (C) Amounts
of radiolabeled F0  F1  F2 protein in particles released from untreated cells (black bars) and mCD-treated cells (gray bars). Particles were
“sorted” with antibodies as indicated and as described in Materials and Methods. Data are represented as percentages of total F0 F1 F2 protein
precipitated with anti-NDV. The no-antibody () values were subtracted from each precipitation. Results are averages of three experiments, and
error bars indicate standard deviations.
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HN-F protein-containing complexes in particles released from
cholesterol-depleted cells could account for their reduced in-
fectivity, since F protein activation is thought to require inter-
actions with HN protein.
Cell surface distribution of viral glycoproteins after choles-
terol depletion. To explore the mechanisms for reduction in
HN and F protein complexes in virions released from mCD-
treated cells, these glycoprotein complexes in infected cells
were characterized. First, the effects of cholesterol depletion
on the cell surface distribution of HN and F proteins were
examined by immunofluorescence microscopy. Both the HN
and F glycoproteins (Fig. 5A and B, respectively) formed small,
distinct foci across the surfaces of untreated avian cells. How-
ever, upon treatment of avian cells with mCD, there was a
dramatic redistribution of both proteins. Several large HN
protein-specific patches formed (Fig. 5A). In contrast, F pro-
tein redistributed primarily to the cell periphery (Fig. 5B). On
the surfaces of infected HEL cells, the HN and F proteins (Fig.
5C and D, respectively) each formed discrete foci. The HN
protein on the surfaces of NPC cells localized in distinct foci,
but the F protein stained diffusely over the cell surface (Fig. 5C
and D, respectively). Qualitatively, the surface localizations of
HN and F proteins on infected NPC cells differed from the
surface localizations of the glycoproteins on mCD-treated
avian cells. These differences may be due to additional effects
that mCD has on the avian cell cytoskeleton. In any event,
loss of plasma membrane cholesterol alters the glycoprotein
surface distribution in both types of cells, and this alteration
results in the same reduction of virus infectivity when particles
are assembled and released from these two cell types. The
redistribution of surface glycoproteins when levels of plasma
membrane cholesterol were decreased, due either to mCD
treatment or to endogenous cholesterol transport defects, sug-
gested that the viral protein-protein interactions in the plasma
membrane may be altered in cells depleted of cholesterol.
Effects of cholesterol depletion on viral glycoprotein com-
plexes in cell extracts. The effects of cholesterol depletion on
the detection of HN and F protein complexes in infected avian
cells were characterized by quantifying the extent of coimmu-
noprecipitation of the two proteins as in Fig. 4. A representa-
tive coimmunoprecipitation is shown in Fig. 6A with quantifi-
cations of multiple experiments shown in Fig. 6B and C. Nearly
75% of the total cell-associated HN protein in untreated cell
extracts was precipitated with F protein-specific antibodies
(Fig. 6B), while in the reciprocal immunoprecipitation, approx-
imately 70% of the total F protein was precipitated with HN
protein-specific antibodies (Fig. 6C). In contrast, only 35% of
the total HN protein in mCD-treated cell extracts was pre-
cipitated with F protein-specific antibodies (Fig. 6B). In the
reciprocal immunoprecipitation, the amount of F protein pre-
cipitated with HN protein-specific antibodies was 20% of the
total F protein (Fig. 6C). The significant reduction in coimmu-
noprecipitation of HN and F proteins after cholesterol deple-
tion strongly indicated that viral protein-protein interactions in
the cells were altered when cellular cholesterol levels were
depleted.
HN-F glycoprotein complexes in cellular DRM fractions.
We have previously reported that NDV assembly occurs in
lipid raft domains (18). If the HN and F protein complexes
detected in total cellular extracts are assembled into virions,
then these complexes should be detected in the cellular DRM
fractions previously characterized (18). Indeed, in untreated
cell extracts, the HN protein in DRM fractions was precipi-
tated with F protein-specific antibodies, although the majority
of HN and F protein complexes were detected in DRM-L
fractions (Fig. 7D). Only F protein in DRM-L fractions was
precipitated with HN protein-specific antibodies (Fig. 7E). Im-
portantly, there was little significant coimmunoprecipitation of
the two proteins from detergent-soluble, nonraft fractions of
untreated cells (Fig. 7), indicating that the HN-F protein com-
plexes reside in lipid raft domains.
As previously reported, in mCD-treated cells, there was a
reduced association of HN and F proteins with DRM-L frac-
FIG. 4. Coimmunoprecipitation of HN and F proteins from virions
released from untreated and mCD-treated avian cells. Purified 35S-
radiolabeled virions released from untreated and mCD-treated
ELL-0 cells were lysed, and proteins were immunoprecipitated (IP)
with a mix of anti-HN protein-specific antibodies or a mix of anti-F
protein-specific antibodies as outlined in Materials and Methods.
-HN, anti-HN antibodies; -F, anti-F antibodies. (A) A representa-
tive autoradiograph of virions from untreated or mCD-treated cells
precipitated with no antibody () or with anti-HN protein or anti-F
protein antibodies. Radiolabeled, precipitated viral proteins are indi-
cated on the right. HN protein lanes were from polyacrylamide gels
electrophoresed under reducing conditions, while F protein lanes were
from polyacrylamide gels electrophoresed under nonreducing condi-
tions. (B) Amounts of radiolabeled HN protein specifically precipitated
with anti-HN protein- or anti-F protein-specific antibodies from solu-
bilized virions released from untreated cells (black bars) or mCD-
treated cells (gray bars). Data are represented as percentages of total
HN protein precipitated with anti-HN protein-specific antibodies set at
100% for each virus. (C) Amounts of radiolabeled F protein specifi-
cally precipitated with anti-F protein- or anti-HN protein-specific an-
tibodies from solubilized virions released from untreated cells (black
bars) or mCD-treated cells (gray bars). Data are represented as
percentages of total F protein precipitated with anti-F protein-specific
antibodies set at 100% for each virus. Results are averages of three
experiments, and error bars indicate standard deviations.
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tions and an increase of the proteins in detergent-soluble frac-
tions of the cell (18) (Fig. 7B and C, respectively). Most im-
portantly, there was very little coimmunoprecipitation of
protein from either the DRM-L or DRM-H fraction or, sig-
nificantly, from detergent-soluble fractions of mCD-treated
cells (Fig. 7D and E). These results indicate that detection of
HN and F protein complexes by coimmunoprecipitation de-
pends upon the presence of cholesterol and membrane raft
integrity.
Effects of virion envelope cholesterol depletion. Although
extraction of cholesterol from virion membranes had no effect
on NDV infectivity (18), the importance of cholesterol in
virion membranes for detection of virion-associated HN-F pro-
tein-containing complexes and in glycoprotein functions was
tested. 35S-radiolabeled virions, generated from untreated
avian cells, were depleted of cholesterol by incubation with
increasing concentrations of mCD and then repurified (Fig.
8). Incubation of particles with 10 mM mCD removed ap-
proximately 90% of virion-associated cholesterol as previously
reported (18). Approximately 40% of the total HN protein
from untreated particles was precipitated with F protein-spe-
cific antibody (Fig. 8A), while in the reciprocal coimmunopre-
cipitation, 40% of total F protein was precipitated with HN
protein-specific antibody (Fig. 8B). Cholesterol extraction of
virion membranes had no effect on the precipitation of HN
protein with F protein-specific antibody (Fig. 8A). The amount
of F protein precipitated with HN protein-specific antibody
was not decreased but rather somewhat increased (55% of
the total) (Fig. 8B).
The cell binding efficiency of untreated particles was approx-
imately 20%, and cholesterol extraction had no significant ef-
fect on virus binding efficiencies (Fig. 8C). Cholesterol extrac-
tion of virions did not inhibit virus-cell membrane fusion as
measured in the R18 hemifusion assay described above (Fig.
8D). Indeed, the hemifusion of mCD-treated particles was
increased by cholesterol extraction. These results indicate that
extraction of cholesterol from the virion envelope did not af-
fect the association of the HN and F glycoproteins nor was it
inhibitory to activities of the two glycoproteins.
DISCUSSION
Results presented here and previously indicate that pertur-
bation of membrane lipid raft domains either by extraction
of cholesterol with mCD or by their aberrant formation in
Niemann-Pick syndrome type C fibroblasts resulted in the ab-
normal assembly and release of relatively noninfectious New-
castle disease virus particles. Particles released from mCD-
treated cells had normal attachment activity but were defective
in fusion of viral and cellular membranes. This reduced fusion
correlated with a significant reduction in detection of HN-F
protein-containing complexes in the virion envelopes of these
particles and with loss of HN and F protein-containing com-
plexes in mCD-treated cells. However, extraction of choles-
FIG. 5. HN and F glycoprotein surface distribution on untreated and mCD-treated avian cells, HEL cells, and NPC cells. (A and B) Surface
distribution of HN protein (A) or F protein (B) on ELL-0 cells as visualized by fluorescence microscopy. Uninfected cells were left untreated. At
7 h postinfection, NDV (AV)-infected cells were left untreated or treated with 10 mM mCD and lovastatin for 1 hour, followed by a 1-hour
recovery incubation in DMEM. Cells were fixed, incubated with antibodies specific for HN protein or F protein (-HN or -F, respectively), and
processed for immunofluorescence microscopy as described in Materials and Methods. (C and D) Surface distribution of HN protein (C) or F
protein (D) on uninfected and NDV (AV)-infected HEL and NPC cells as visualized by fluorescence microscopy. At 8 h postinfection, cells were
fixed, stained for surface HN protein or F protein, and processed for immunofluorescence microscopy as described in Materials and Methods.
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terol from virion membranes did not affect these preformed
HN and F protein complexes. Taken together, these results
suggest that membrane lipid rafts facilitate the necessary viral
protein-protein interactions for the proper assembly of infec-
tious NDV particles.
Assembly and release of virus from NPC cells. Because
mCD has been shown to not only disrupt membrane lipid
rafts but also to affect cytoskeleton organization (17), it was
important to characterize assembly and release of particles
from cells with membrane lipid rafts disordered by another
mechanism. NPC cells are reported to have altered membrane
lipid raft domains (9, 10, 22, 39, 44). These cells were derived
from humans with a specific lysosomal storage disorder (14).
The NPC disease is primarily due to a mutation(s) in the NPC1
gene, which encodes a protein involved in the transport of
low-density-lipoprotein-derived cholesterol (14, 46) and likely
endogenously synthesized cholesterol (35) to various or-
ganelles, including the plasma membrane. In NPC cells, cho-
lesterol, as well as raft-associated sphingolipids (39), accumu-
late in late endosomes and lysosomes. The actual level of
cholesterol in the plasma membranes of NPC cells is contro-
versial (2, 4, 20, 44), but it is clear that the lipid organization
and function of membrane rafts at the plasma membrane of
these cells are abnormal (2, 11, 16, 44).
NPC cells and wild-type counterpart (HEL) cells were
equally permissive to NDV infection, and both NDV glycopro-
teins were found at comparable levels on the surfaces of in-
fected HEL and NPC cells. Importantly, the actin cytoskeleton
of NPC cells was similar to that observed for the control HEL
cells. However, there was reduced association of the viral pro-
teins with DRMs from NPC cells compared to HEL cells,
consistent with altered membrane lipid rafts in NPC cells.
Similar to previous results with mCD-treated avian cells (18),
particles released from NPC cells were characterized by irreg-
ular protein composition and reduced infectivity compared to
particles released from control HEL cells. These results sug-
gest that abnormal membrane lipid rafts, due to mutation in
cholesterol transport, have effects on the assembly of infectious
virus similar to the effects of disruption of membrane lipid rafts
by cholesterol extraction with mCD. The results are consis-
tent with the conclusion that the integrity of membrane lipid
rafts is important for the proper assembly and release of in-
fectious virions.
Effects of infected-cell cholesterol depletion on released viri-
ons. Disruption of infected-cell lipid raft domains resulted in
release of virions with reduced infectivity, and the results
shown here suggest that reduced infectivity was not due to loss
of virus-cell attachment but may be attributed to defects in
virus-cell membrane fusion. The fusion defect may be due to
either insufficient levels of F protein incorporation into parti-
cles or due to packaging of inactive F proteins. Experiments
“sorting” particles with HN protein- or F protein-specific an-
tibodies showed that most virions, whether derived from un-
treated or mCD-treated cells, contained both glycoproteins.
Furthermore, that all particles contained HN protein was
shown by the observation that the cell binding of particles
released from untreated and mCD-treated cells was identical.
One limitation to this experimental sorting approach is the
inability to determine the relative levels of each glycoprotein
packaged into a single particle. It is possible that there are
particles with low levels of incorporated HN protein or F
protein, which could potentially impact the overall infectivity
of the virion population. Nonetheless, most particles released
from mCD-treated cells possessed both HN and F glycopro-
teins, suggesting that the packaged F proteins may be inactive.
Studies of cell-cell membrane fusion mediated by paramyxo-
virus glycoproteins have shown that fusion requires activation
of the F protein by the homologous viral attachment protein
following cell attachment (19). The activated F protein then
proceeds through a series of conformational changes that ini-
tiate hemifusion, pore formation, and pore expansion (19).
FIG. 6. Coimmunoprecipitation of viral glycoproteins from cellular
extracts of untreated and mCD-treated avian cells. Monolayers of
NDV(AV)-infected ELL-0 cells were pulse-labeled with [35S]methi-
onine/cysteine at 6 h postinfection and then subjected to a 1-hour
nonradioactive chase. Cells were then left untreated () or treated
with 10 mM mCD and lovastatin for 1 hour (), incubated in DMEM
for 1 hour, and then lysed as described in Materials and Methods.
Proteins in extracts were immunoprecipitated (IP) with a mix of
anti-HN protein-specific antibodies (-HN) or a mix of anti-F protein-
specific antibodies (-F) as outlined in Materials and Methods. To
detect total F (F0 F1 F2) protein, proteins were electrophoresed in
the absence of reducing agent. (A) A representative autoradiograph of
cell extracts from untreated or mCD-treated cells precipitated with
no antibody () or with anti-HN protein or anti-F protein antibodies.
Radiolabeled viral proteins are indicated on the right. (B) Amounts of
radiolabeled HN protein specifically precipitated with anti-HN pro-
tein- or anti-F protein-specific antibodies from cellular extracts of
untreated cells (black bars) or mCD-treated cells (gray bars). Data
are represented as percentages of total HN protein precipitated with
anti-HN protein-specific antibodies set at 100% for each cell extract.
(C) Amounts of radiolabeled F protein precipitated with anti-F pro-
tein- or anti-HN protein-specific antibodies from cellular extracts of
untreated cells (black bars) or mCD-treated cells (gray bars). Data
are represented as percentages of total F protein precipitated with
anti-F protein-specific antibodies set at 100% for each cell extract.
Results are averages of three experiments, and error bars indicate
standard deviations.
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Because virions released from cholesterol-deficient cells were
defective in hemifusion, the first step in membrane fusion, it
was possible that these virions were defective in F protein
activation. Failure to activate the F protein could be due to loss
of necessary HN and F protein-containing complexes required
for membrane fusion. To test the possibility that virus released
from mCD-treated cells had reduced HN and F protein com-
plexes, the levels of these complexes in particles released from
untreated cells were first determined. There have been numer-
ous reports of paramyxovirus attachment protein and fusion
protein complexes in infected and transfected cells (1, 5, 21, 34,
42). Indeed, NDV HN and F protein complexes were effi-
ciently detected in transiently transfected HN and F protein-
expressing cells (24). However, there has been very little char-
acterization of associations between glycoproteins within
paramyxovirus particles. Using conditions previously utilized
to detect NDV HN and F protein complexes in cellular extracts
of transfected cells (24), HN and F protein complexes were
detected in virions. However, while 70% and 60% of total HN
and F protein, respectively, in infected-cell extracts were pre-
cipitated with heterologous antibody, only 40% of the total
virion-associated HN protein and 35% of the total virion-
FIG. 7. Immunoprecipitation of viral proteins from DRM cell fractions derived from untreated and mCD-treated avian cells. Cellular extracts
of NDV(AV)-infected ELL-0 cells, untreated () or treated with 10 mM mCD and lovastatin (), were prepared as described in the legend to
Fig. 6 and separated into DRM-L, DRM-H, and detergent-soluble fractions as described in the legend to Fig. 1C. Gradient fractions corresponding
to the three cellular fractions as indicated in Fig. 1C were pooled, and proteins were immunoprecipitated (IP) with mono-specific antibodies. (A) A
representative autoradiograph of proteins precipitated from gradient fractions (Sol, detergent-soluble gradient fractions; DRM-H, heavy [high-
density] DRM gradient fractions; DRM-L, light [low-density] DRM gradient fractions) derived from untreated or mCD-treated cells precipitated
with no antibody () or with anti-HN protein- or anti-F protein-specific antibodies. Radiolabeled viral proteins are indicated on the right.
(B) Radiolabeled HN protein specifically precipitated with anti-HN protein-specific antibodies from indicated cellular fractions of untreated cells
(black bars) or mCD-treated cells (gray bars). Data are represented as absolute HN protein levels (arbitrary [arb.] densitometer units)
precipitated with anti-HN protein-specific antibodies. (C) Radiolabeled F protein specifically precipitated with anti-F protein-specific antibodies
from indicated cellular fractions of untreated cells (black bars) or mCD-treated cells (gray bars). Data are represented as absolute F protein levels
(arbitrary densitometer units) precipitated with anti-F protein-specific antibodies. (D) Radiolabeled HN protein specifically precipitated with
anti-F protein-specific antibodies from indicated cellular fractions of untreated cells (black bars) or mCD-treated cells (gray bars). Data are
represented as absolute HN protein levels (arbitrary densitometer units) precipitated with anti-F protein-specific antibodies. (E) Radiolabeled F
protein specifically precipitated with anti-HN protein-specific antibodies from indicated cellular fractions of untreated cells (black bars) or
mCD-treated cells (gray bars). Data are represented as absolute F protein levels (arbitrary densitometer units) precipitated with anti-HN
protein-specific antibodies. Results are averages of three experiments, and error bars indicate standard deviations.
VOL. 81, 2007 LIPID RAFTS AND ASSEMBLY OF NDV GLYCOPROTEIN COMPLEXES 10645
 at UNIV O
F M
ASS M
ED SCH on Decem
ber 26, 2008 
jvi.asm.org
D
ow
nloaded from
 
associated F protein could be precipitated with heterologous
antibody. These results suggest that virion-associated glycopro-
teins are heterogeneous and that packaging of glycoproteins
into virions selects individual glycoprotein oligomers along
with HN and F protein complexes.
The detection of HN and F protein-containing complexes in
the envelopes of particles released from mCD-treated cells
was significantly reduced. As it is well-documented that
paramyxovirus cell-cell fusion is dependent on F protein inter-
actions with homologous viral attachment proteins (13), the
reduction in hemifusion between particles released from
mCD-treated cells and target cell membranes may be attrib-
uted to the reduction of HN and F protein complexes. While it
cannot be ruled out that HN and F protein complexes are
reduced due to altered ratios of HN and F proteins in individ-
ual particles, given the existence of near-normal levels of virion
F1 protein in particles released from mCD-treated cells (18),
it seems more likely that virion-incorporated F protein is non-
functional due to loss of interactions with virion-incorporated
HN protein.
Effects of cholesterol depletion on glycoprotein complexes in
infected cells. The reduction of HN and F protein complexes in
virus released from mCD-treated cells and the altered cell
surface distribution of the two glycoproteins after cholesterol
extraction suggested that membrane lipid raft integrity may
have a role in detection of HN and F protein complexes in cell
extracts. In fact, cell-associated HN-F protein-containing com-
plexes were detected exclusively in cellular DRM fractions and
were not detected in detergent-soluble fractions of cells. Strik-
ingly, cholesterol extraction resulted in significantly reduced
detection of glycoprotein complexes in total extracts and in
residual DRM domains. Significantly, HN and F protein com-
plexes did not shift to detergent-soluble fractions of mCD-
treated cells, suggesting that the integrity of membrane lipid
raft domains is important for the formation or maintenance of
these complexes. Preliminary data also demonstrated a signif-
icant loss in detection of these complexes specifically from
cellular DRM fractions of infected NPC cells (J. Laliberte and
T. Morrison, unpublished data).
Recently, Ono et al. described a role for cholesterol in fa-
cilitating viral protein-protein interactions at membrane raft
domains (31). Depletion of cellular cholesterol by mCD
treatment reduced the ability of human immunodeficiency vi-
rus type 1 Gag protein to multimerize and fractionate with
DRMs, resulting in impaired virus release (31). These results
are consistent with those presented here and suggest that cho-
lesterol and membrane lipid raft integrity is important for viral
protein interactions and assembly of infectious virions.
Effects of cholesterol depletion on virion-associated glyco-
protein complexes. To address the roles of membrane lipid
rafts in the formation and maintenance of glycoprotein com-
plexes, cholesterol was extracted from normal virions. Re-
moval of approximately 90% of virion-associated cholesterol
(18) did not affect detection of HN and F protein complexes,
indicating that, once formed and incorporated into virions,
these complexes were not dependent upon membrane lipid raft
FIG. 8. Effects of cholesterol extraction from virions on viral glycoprotein interactions and activities. 35S-radiolabeled virions released from
untreated NDV (AV)-infected ELL-0 cells were left untreated () or depleted of cholesterol with 2.5, 5, or 10 mM mCD () for 1 h at 37°C
and then repurified as described in Materials and Methods. IP, immunoprecipitate; - HN, anti-HN antibodies; -F, anti-F antibodies. (A) Levels
of coimmunoprecipitation of HN protein from solubilized particles either untreated (black bars) or treated with 10 mM mCD (gray bars) as
described in the legend to Fig. 4 and in Materials and Methods. Results are averages of three experiments, and error bars indicate standard
deviations. (B) Levels of coimmunoprecipitation of F protein from solubilized particles either untreated (black bars) or treated with 10 mM mCD
(gray bars) as described in the legend to Fig. 4 and in Materials and Methods. Results are averages of three experiments, and error bars indicate
standard deviations. (C) Virus-cell binding efficiency, measured as described in the legend to Fig. 2, of particles left untreated (black bar) or treated
with 10 mM mCD (gray bar). Inhibition of cell binding by preincubation of virions with anti-NDV antibody is shown in white bars. Results are
averages of three experiments, and error bars indicate standard deviations. (D) Extent of virus-cell membrane hemifusion, measured as described
in the legend to Fig. 2 and Materials and Methods, for particles left untreated or treated with increasing concentrations of mCD. The R18
fluorescence (in arbitrary [arb.] units) of target erythrocytes at 1 h at 37°C is shown for each sample. Results are averages of three experiments,
and error bars indicate standard deviations.
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integrity. Supporting this conclusion was the observation that
cholesterol extraction of virion envelopes had no effect on
particle infectivity (18), virus-cell attachment, or virus-cell
hemifusion. Also consistent with this conclusion are results
reported by Dolganiuc et al. examining the role of cholesterol
in cell-cell fusion by NDV HN and F protein-expressing cells
(6). HN and F protein-expressing cells, which were acutely
depleted of cholesterol with mCD, fused R18-loaded target
erythrocytes to levels similar to those of HN and F protein-
expressing cells left untreated (6). Thus, extraction of choles-
terol had no effect on F protein activation and therefore, per-
haps, the integrity of these preformed HN and F protein
complexes. Together, these results suggest that once formed,
HN and F protein complexes in virions, and perhaps in cells,
are stable and functional after cholesterol removal. Although
the stability of these glycoprotein complexes in cells is under
investigation, the results support the hypothesis that forma-
tion, and not maintenance, of the NDV HN and F protein
complex is cholesterol/membrane lipid raft-dependent. Detec-
tion of HN and F protein complexes in the mutant NPC cells
is significantly reduced in comparison to the wild-type HEL
cells (Laliberte and Morrison, unpublished). This result sug-
gests that proper association of the glycoproteins with normal
membrane lipid rafts may be essential for the formation of the
glycoprotein complex following biosynthesis. The residual fu-
sion activity and low levels of HN and F protein complexes
detected in virus released from mCD-treated cells could be
due to complexes formed during the 2 hours of pulse-chase
labeling prior to cholesterol extraction of infected-cell mem-
branes.
In conclusion, the results presented here show that extrac-
tion of cholesterol from infected-cell membranes, but not
virion envelopes, decreases the infectivity of released virus by
hindering the packaging of functional F proteins into virions.
Results are consistent with the proposal that cholesterol, and
its role in maintaining membrane lipid raft domains in NDV-
infected cells, facilitates the formation or maintenance of
HN-F protein complexes and, therefore, the virion incorpora-
tion of glycoprotein complexes capable of initiating virus-cell
membrane fusion.
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